Kennedy and Martin Luther King Jr. The JFK assassination has long been the subject of conspiracy theories, with long calls for the government to release remaining records that are still classified.

Jefferies analyst Dennis Ding initiated coverage of Rhythm Pharmaceuticals (RYTM) with a Buy rating and $80 price target Discover the latest stocks recommended by top Wall Street analysts ...

After decades in the shadows as a catalog company, historic Sun Records was acquired four years ago by the global music and media company Primary Wave. Now headquartered in Brentwood, a refreshed Sun ...

Want to get your hands on some free gems and EXP boosts in King Legacy? You're in luck. These redeemable codes will net you a bunch of rewards in King Legacy, earning you everything from iron keys ...

The family of Martin Luther King Jr. has responded to the news of President Donald Trump’s executive order to declassify the remaining federal records relating to King’s assassination in Memphis, ...

A genre of music-themed action video game that challenges players to focus on dance or the simulated performance of musical instruments, and requires them to press buttons in a sequence dictated on ...

ATLANTA, Ga. (Atlanta News First) - The King family has released a statement after President Donald Trump signed an executive order declassifying records related to the assassination of Dr. Martin ...

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

President Donald J. Trump has signed an executive order mandating the full declassification and release of all remaining federal records related to the assassinations of President John F. Kennedy, ...

Trump signed on Thursday (January 23, 2025) also aims to declassify the remaining federal records relating to the assassinations of Sen. Robert F. Kennedy and the Rev. Martin Luther King Jr.

“Rhythm enters 2025 poised for the next level of growth. Over the past two years, we have established the commercial viability of our rare MC4R pathway diseases franchise by demonstrating steady ...